Appetite hormone misfires in obese people

Glucagon, a hormone involved in regulating appetite, loses its ability to help obese people feel full after a meal, but it continues to suppress hunger pangs in people with type 1 diabetes, according to a recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM).

The primary role of glucagon, a secreted by the pancreas, is to signal the body to release stored glucose when blood sugar falls too low. But growing evidence suggests the hormone also may play a role in controlling food intake and feelings of fullness, or satiation, through signaling the body to reduce levels of other appetite hormones like ghrelin.

"Once a person becomes obese, glucagon no longer induces feelings of fullness," said the study's lead author, Ayman M. Arafat, MD, of Charité-University Medicine in Berlin, Germany. "Further research is needed to determine why glucagon no longer suppresses appetite effectively in this population, even though they are otherwise healthy."

The prospective, double-blinded, placebo-controlled study investigated glucagon levels and appetite among 11 , 13 people with and 13 lean people. Participants received injections of either glucagon or a placebo. Researchers then measured participants' appetites using a satiety scale as well as levels of the hormone ghrelin.

Feelings of fullness did not differ between obese study participants who received glucagon injections and those who were given the placebo. In comparison, participants who were lean or had type 1 reported feeling significantly more full after receiving glucagon. The response to the hormone was detectable in this population, even 24 hours after it was administered.

"The findings could influence efforts to develop new treatments for obesity and diabetes," Arafat said. "Although therapeutic agents that influence glucagon and other hormones currently are considered a promising avenue for research, this study suggests a treatment involving may be ineffective in controlling meal size in people who are obese."

More information: The article, "The Impact of Insulin-independent Glucagon-induced Suppression of Total-Ghrelin on Satiety in Obesity and Type 1 Diabetes Mellitus," was published online Aug. 20.

add to favorites email to friend print save as pdf

Related Stories

New findings on glucagon synthesis

Dec 03, 2012

Researchers at Karolinska Institutet in Sweden have shown that the cells that produce glucagon are stimulated by the hormone itself. A previous study by the same group demonstrated that this principle also applies to insulin. ...

Recommended for you

Abdominal obesity ups risk of hip fracture

Feb 27, 2015

(HealthDay)—Abdominal obesity is associated with increased risk of hip fracture, according to a study published in the March issue of the Journal of Internal Medicine.

Does traffic noise increase the risk of obesity?

Feb 27, 2015

There is an association between road traffic noise and the risk of obesity among people who are particularly sensitive to noise, according to a study from the Norwegian Institute of Public Health.

Impact of a supermarket on children's diets

Feb 26, 2015

Locating full-service supermarkets within neighborhoods considered to be "food deserts" may not result in healthful dietary habits or reductions in childhood obesity—at least in the short term, according to a new study ...

Seeking solutions for the impact of obesity stigma

Feb 26, 2015

Arizona State University medical anthropologist and President's Professor Alexandra Brewis Slade says that even as more and more Americans find themselves carrying extra weight, the stigma attached to being ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.